Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

Thu, 28th May 2020 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

UBS RAISES BURBERRY PRICE TARGET TO 983 (959) PENCE - 'SELL'

----------

KEPLER CHEUVREUX CUTS VODAFONE PRICE TARGET TO 170 (175) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES HARGREAVES LANSDOWN TARGET TO 1380 (1225) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES EXPERIAN TARGET TO 2440 (2400) PENCE - 'EQUAL-WEIGHT'

----------

DEUTSCHE BANK CUTS BRITISH LAND CO PRICE TARGET TO 475 (550) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES M&G PRICE TARGET TO 210 (200) PENCE - 'BUY'

----------

BARCLAYS RAISES INTERMEDIATE CAPITAL TARGET TO 1520 (1470) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES CRODA INTERNATIONAL TARGET TO 4100 (3900) PENCE - 'UNDERPERFORM'

----------

FTSE 250

----------

JEFFERIES INITIATES GREGGS WITH 'BUY' - TARGET 2375 PENCE

----------

JEFFERIES INITIATES GAMES WORKSHOP GROUP WITH 'BUY' - TARGET 8500 PENCE

----------

JEFFERIES RAISES BRITVIC PRICE TARGET TO 850 (800) PENCE - 'BUY'

----------

JEFFERIES CUTS BEAZLEY PRICE TARGET TO 500 (575) PENCE - 'BUY'

----------

LIBERUM RAISES PAYPOINT PRICE TARGET TO 1000 (800) PENCE - 'BUY'

----------

DAVY RAISES TRAVIS PERKINS TO 'NEUTRAL' ('UNDERPERFORM')

----------

BARCLAYS CUTS TATE & LYLE PRICE TARGET TO 730 (800) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS PROVIDENT FINANCIAL TARGET TO 405 (510) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES HAYS TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 120 (105) P

----------

RBC CUTS PROVIDENT FINANCIAL PRICE TARGET TO 195 (210) PENCE - 'SECTOR PERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

JPMORGAN CUTS DAILY MAIL PRICE TARGET TO 800 (950) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE CUTS DAILY MAIL PRICE TARGET TO 708 (757) PENCE - 'NEUTRAL'

----------

LIBERUM RAISES CLINIGEN PRICE TARGET TO 1050 (850) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 Dec 2021 08:16

Clinigen to be taken private by Triton in £1.2bn deal, shares surge

(Sharecast News) - Clinigen surged on Wednesday after agreeing to be taken private by European investment firm Triton in a £1.2bn deal.

Read more
2 Dec 2021 14:28

Shares in Clinigen surge on takeover talks with Triton Investment

Shares in Clinigen surge on takeover talks with Triton Investment

Read more
2 Dec 2021 12:59

Clinigen confirms takeover talks with Triton, shares surge

(Sharecast News) - Clinigen shares surged on Thursday after the company confirmed it has received a non-binding indicative proposal from investment firm Triton about a possible offer.

Read more
2 Dec 2021 09:52

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

Read more
1 Dec 2021 13:42

Clinigen's leukaemia treatment Erwinase fails to gain approval in US

Clinigen's leukaemia treatment Erwinase fails to gain approval in US

Read more
29 Nov 2021 11:21

Clinigen signs exclusive agreement with Nippon Shinyaku on Viltepso

Clinigen signs exclusive agreement with Nippon Shinyaku on Viltepso

Read more
25 Nov 2021 16:01

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
17 Nov 2021 16:01

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
5 Nov 2021 09:55

Liberum lowers target price on Clinigen

(Sharecast News) - Analysts at Liberum lowered their target price on pharmaceutical services and products group Clinigen from 886.0p to 800.0p on Friday but stated risks still appeared to be "skewed to the upside".

Read more
8 Oct 2021 08:46

Clinigen and Humanigen partner to progress investigational Covid drug

Clinigen and Humanigen partner to progress investigational Covid drug

Read more
22 Sep 2021 19:31

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

Read more
22 Sep 2021 13:34

Clinigen to distribute 'Copiktra' in most of Europe

(Sharecast News) - Pharmaceutical products and services provider Clinigen has signed an exclusive agreement with Secura Bio for the supply and distribution of 'Copiktra' in most of Europe, it announced on Wednesday.

Read more
16 Sep 2021 12:29

Clinigen cuts full-year earnings forecasts, shares fall

(Sharecast News) - Shares in Clinigen Group fell on Thursday after the pharmaceuticals specialist cut its full-year earnings forecast.

Read more
16 Sep 2021 12:07

Clinigen shares fall on lowered outlook as profit more than doubles

Clinigen shares fall on lowered outlook as profit more than doubles

Read more
16 Sep 2021 10:55

AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls

AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.